| A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (NCT06977568) | Pacira Pharmaceuticals, Inc | 2025-07-25 |
| A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee (NCT06884865) | Pacira Pharmaceuticals, Inc | 2025-02-26 |
| Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity (NCT06340451) | Pacira Pharmaceuticals, Inc | 2024-07-11 |
| Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery (NCT06271265) | Pacira Pharmaceuticals, Inc | 2024-03-29 |
| Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers (NCT05456490) | Pacira Pharmaceuticals, Inc | 2023-04-18 |
| Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy (NCT05157841) | Pacira Pharmaceuticals, Inc | 2022-02-15 |
| Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty (NCT05139030) | Pacira Pharmaceuticals, Inc | 2022-01-18 |
| Innovations in Genicular Outcomes Registry (NCT05495334) | Pacira Pharmaceuticals, Inc | 2021-09-23 |
| Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy (NCT04826328) | Pacira Pharmaceuticals, Inc | 2021-03-15 |
| Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries (NCT04518462) | Pacira Pharmaceuticals, Inc | 2020-10-20 |
| Study to Evaluate Iovera®° in Adult Patients Undergoing Total Knee Arthroplasty (NCT04191031) | Pacira Pharmaceuticals, Inc | 2020-09-30 |
| Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries (NCT03954639) | Pacira Pharmaceuticals, Inc | 2020-06-15 |
| Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers (NCT04173611) | Pacira Pharmaceuticals, Inc | 2020-06-08 |
| Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation (NCT04293809) | Pacira Pharmaceuticals, Inc | 2019-12-19 |
| Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis (NCT04160091) | Pacira Pharmaceuticals, Inc | 2019-11-07 |
| EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture (NCT03955458) | Pacira Pharmaceuticals, Inc | 2019-08-26 |
| Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine Surgeries (NCT03927911) | Pacira Pharmaceuticals, Inc | 2019-07-31 |
| Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip (NCT04065074) | Pacira Pharmaceuticals, Inc | 2019-07-30 |
| Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy (NCT04002089) | Pacira Pharmaceuticals, Inc | 2019-07-26 |
| Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction (NCT03909516) | Pacira Pharmaceuticals, Inc | 2019-05-01 |
| Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL (NCT03682302) | Pacira Pharmaceuticals, Inc | 2019-04-02 |
| Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section (NCT03853694) | Pacira Pharmaceuticals, Inc | 2019-03-04 |
| Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis (NCT03793010) | Pacira Pharmaceuticals, Inc | 2018-12-12 |
| Iovera° to Treat Pain Associated With ACL Reconstruction and Rehabilitation (NCT03688477) | Pacira Pharmaceuticals, Inc | 2018-10-01 |
| Study in Adult Subjects Undergoing Posterolateral Thoracotomy (NCT03428984) | Pacira Pharmaceuticals, Inc | 2018-05-03 |
| Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee (NCT03529942) | Pacira Pharmaceuticals, Inc | 2018-04-24 |
| Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip (NCT03382262) | Pacira Pharmaceuticals, Inc | 2017-12-18 |
| Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA (NCT03378076) | Pacira Pharmaceuticals, Inc | 2017-12-06 |
| Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain (NCT03327220) | Pacira Pharmaceuticals, Inc | 2017-11-06 |